KR102397334B1 - 2성분 조성물 - Google Patents

2성분 조성물 Download PDF

Info

Publication number
KR102397334B1
KR102397334B1 KR1020197001083A KR20197001083A KR102397334B1 KR 102397334 B1 KR102397334 B1 KR 102397334B1 KR 1020197001083 A KR1020197001083 A KR 1020197001083A KR 20197001083 A KR20197001083 A KR 20197001083A KR 102397334 B1 KR102397334 B1 KR 102397334B1
Authority
KR
South Korea
Prior art keywords
component
aqueous solution
asa
salt
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197001083A
Other languages
English (en)
Korean (ko)
Other versions
KR20190040184A (ko
Inventor
존 비요른 프레드릭손
Original Assignee
아사메딕 에이에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아사메딕 에이에스 filed Critical 아사메딕 에이에스
Publication of KR20190040184A publication Critical patent/KR20190040184A/ko
Application granted granted Critical
Publication of KR102397334B1 publication Critical patent/KR102397334B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/072—Sealing capsules, e.g. rendering them tamper-proof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074—Filling capsules; Related operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
KR1020197001083A 2016-06-28 2017-06-28 2성분 조성물 Active KR102397334B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20161073 2016-06-28
NO20161073 2016-06-28
PCT/EP2017/065970 WO2018002124A1 (en) 2016-06-28 2017-06-28 Two-component composition

Publications (2)

Publication Number Publication Date
KR20190040184A KR20190040184A (ko) 2019-04-17
KR102397334B1 true KR102397334B1 (ko) 2022-05-11

Family

ID=59285173

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197001083A Active KR102397334B1 (ko) 2016-06-28 2017-06-28 2성분 조성물

Country Status (25)

Country Link
US (3) US11918554B2 (enExample)
EP (2) EP3871677A1 (enExample)
JP (2) JP2019520377A (enExample)
KR (1) KR102397334B1 (enExample)
CN (2) CN109789152A (enExample)
AU (1) AU2017288465B2 (enExample)
BR (1) BR112018076553A2 (enExample)
CA (1) CA3027462A1 (enExample)
CY (1) CY1124724T1 (enExample)
DK (1) DK3474858T3 (enExample)
EA (1) EA201990093A1 (enExample)
ES (1) ES2897981T3 (enExample)
HR (1) HRP20211761T1 (enExample)
HU (1) HUE056659T2 (enExample)
IL (1) IL263982B (enExample)
LT (1) LT3474858T (enExample)
MX (1) MX388400B (enExample)
MY (1) MY195384A (enExample)
NZ (1) NZ749230A (enExample)
PL (1) PL3474858T3 (enExample)
PT (1) PT3474858T (enExample)
RS (1) RS62574B1 (enExample)
SI (1) SI3474858T1 (enExample)
SM (1) SMT202100645T1 (enExample)
WO (1) WO2018002124A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3474858T (lt) 2016-06-28 2021-12-27 Asamedic As Dviejų komponentų kompozicija, apimanti acetilsalicilo rūgštį
EP3501522A1 (en) 2017-12-22 2019-06-26 Asamedic AS Compositions comprising acetylsalicylic acid and a phosphate salt
EP3501523A1 (en) 2017-12-22 2019-06-26 Asamedic AS Two-component compositions comprising acetyl salicylic acid and a carbonate salt
WO2020150460A1 (en) * 2019-01-18 2020-07-23 Milne Iii Donald A Micronized aspirin formulation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100351193B1 (ko) 1993-11-26 2002-12-31 라보라뚜와르 위뻬에스아 아세틸살리실산메토클로프라미드화합물로구성된활성성분을갖는산제제조용조성물
US20070092561A1 (en) 2005-06-24 2007-04-26 Don Milne Water-Soluble Aspirin Composition

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB912894A (en) * 1959-11-02 1962-12-12 Guy Leopold Van Moorleghem Method for the preparing a solution of aspirin for injection and product obtained thereby
AT222276B (de) * 1959-11-02 1962-07-10 Guy Leopold Van Moorleghem Verfahren zur Herstellung einer injizierbaren Lösung von Acetylsalicylsäure
FR304M (fr) * 1960-08-19 1961-03-20 Guy Soluté injectable d'aspirine et son procédé de fabrication.
FR2320759A1 (fr) 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
AU632602B2 (en) 1989-08-02 1993-01-07 John David Arnold Method and preparation for reducing risk of myocardial infarction
US5157030A (en) 1989-08-25 1992-10-20 Alexander Galat Rapidly soluble aspirin compositions and method
JPH07157432A (ja) * 1993-12-07 1995-06-20 Daikyo Yakuhin Kogyo Kk 貼付剤
GB9701160D0 (en) * 1997-01-21 1997-03-12 Parkinson Sidney Medicament dispenser
IT1292677B1 (it) 1997-02-28 1999-02-11 Bormioli Metalplast Spa Confezione per mantenere separati dei prodotti prima dell'uso.
US5776431A (en) 1997-03-26 1998-07-07 Galat; Alexander Water-soluble aspirin composition
JP4126405B2 (ja) * 1998-02-02 2008-07-30 甲陽ケミカル株式会社 芳香族カルボン酸類の溶解度向上化水溶液
NO309761B1 (no) * 1999-05-03 2001-03-26 Anders Aelveborn Beholder eller kapsel for adskilt oppbevaring av to- komponents blandbare materialer
GB0018322D0 (en) * 2000-07-27 2000-09-13 Boots Co Plc Pharmaceutical compositions
US7029701B2 (en) 2000-09-11 2006-04-18 Andrx Pharmaceuticals, Llc Composition for the treatment and prevention of ischemic events
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
EP1525765A1 (en) 2002-06-25 2005-04-27 Nokia Corporation Routing method and network element
ITMI20022619A1 (it) 2002-12-11 2004-06-12 Ind Italiana Integratori Trei S P A Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata.
CN1418635A (zh) * 2002-12-19 2003-05-21 王登之 治疗感冒发热的阿司匹林口腔崩解片及其制备方法
EP1621200A1 (en) * 2004-07-26 2006-02-01 Fournier Laboratories Ireland Limited Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate
US7598233B2 (en) * 2005-03-28 2009-10-06 Kowa Co., Ltd. Method for treating thrombosis
US20060292225A1 (en) 2005-06-24 2006-12-28 Felix Arthur M Water soluble analgesic formulations and methods for production
US7614496B2 (en) 2005-08-29 2009-11-10 Steven Dvorak Aqueous solution of an analgesic and a dispenser therefor
WO2009007768A1 (en) 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
CN101632647A (zh) * 2008-07-21 2010-01-27 北京迈劲医药科技有限公司 阿司匹林与碱性药物组成的复方制剂的制备方法
US20100125242A1 (en) * 2008-11-15 2010-05-20 Pharmstar Pharmaceuticals, Inc. Emergency dose medication administration device
WO2010065936A1 (en) * 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
US8173625B2 (en) * 2009-05-08 2012-05-08 Theaprin Pharmaceuticals Inc. Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
US8580853B2 (en) 2011-06-13 2013-11-12 Howard PHYKITT Analgesic composition and method of making the same
HUE039878T2 (hu) * 2012-09-25 2019-02-28 Bayer Pharma AG Regorafenib és acetilszalicilsav kombinációja kolorektális rák kezelésére
PT3060203T (pt) 2013-10-23 2017-10-27 Bayer Healthcare Llc Comprimido efervescente que contém um teor elevado de aspirina
EP2777802B1 (en) 2013-12-03 2016-03-16 Capsugel Belgium NV Multi-compartment dosage form articles
WO2017001468A1 (en) * 2015-07-02 2017-01-05 Asamedic As Two-component composition
LT3474858T (lt) 2016-06-28 2021-12-27 Asamedic As Dviejų komponentų kompozicija, apimanti acetilsalicilo rūgštį
EP3501523A1 (en) 2017-12-22 2019-06-26 Asamedic AS Two-component compositions comprising acetyl salicylic acid and a carbonate salt
EP3501522A1 (en) 2017-12-22 2019-06-26 Asamedic AS Compositions comprising acetylsalicylic acid and a phosphate salt

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100351193B1 (ko) 1993-11-26 2002-12-31 라보라뚜와르 위뻬에스아 아세틸살리실산메토클로프라미드화합물로구성된활성성분을갖는산제제조용조성물
US20070092561A1 (en) 2005-06-24 2007-04-26 Don Milne Water-Soluble Aspirin Composition

Also Published As

Publication number Publication date
MY195384A (en) 2023-01-18
DK3474858T3 (da) 2021-11-22
HUE056659T2 (hu) 2022-03-28
ES2897981T3 (es) 2022-03-03
BR112018076553A2 (pt) 2019-04-02
US11369581B2 (en) 2022-06-28
IL263982A (en) 2019-01-31
PL3474858T3 (pl) 2022-01-17
WO2018002124A1 (en) 2018-01-04
CA3027462A1 (en) 2018-01-04
MX388400B (es) 2025-03-20
CY1124724T1 (el) 2022-07-22
IL263982B (en) 2022-03-01
PT3474858T (pt) 2021-11-22
EA201990093A1 (ru) 2019-07-31
CN117982446A (zh) 2024-05-07
JP2019520377A (ja) 2019-07-18
JP2023027071A (ja) 2023-03-01
KR20190040184A (ko) 2019-04-17
MX2018015965A (es) 2019-05-22
HRP20211761T1 (hr) 2022-02-18
AU2017288465A1 (en) 2019-01-17
US11918554B2 (en) 2024-03-05
NZ749230A (en) 2023-05-26
US20220218724A1 (en) 2022-07-14
SI3474858T1 (sl) 2022-01-31
US20210212976A1 (en) 2021-07-15
EP3871677A1 (en) 2021-09-01
JP7520941B2 (ja) 2024-07-23
SMT202100645T1 (it) 2022-01-10
US20240216318A1 (en) 2024-07-04
AU2017288465B2 (en) 2019-10-10
EP3474858B1 (en) 2021-08-18
EP3474858A1 (en) 2019-05-01
CN109789152A (zh) 2019-05-21
LT3474858T (lt) 2021-12-27
RS62574B1 (sr) 2021-12-31

Similar Documents

Publication Publication Date Title
JP7520941B2 (ja) 二成分組成物およびカプセル
JP5529165B2 (ja) 脂質低下薬を経口腔粘膜投与する処方物（ｆｏｒｍｕｌａｔｉｏｎ）
EP3727396B1 (en) Two-component systems comprising acetylsalicylic acid and a carbonate salt
EP3727395B1 (en) Two-component systems comprising acetylsalicylic acid and a phosphate salt
US9561204B2 (en) Effervescent compositions containing N-acetylcysteine
EP2919744A1 (en) Effervescent tablet
WO2017001468A1 (en) Two-component composition
HK40007246B (en) Two-component composition comprising acetylsalicylic acid
EA048875B1 (ru) Двухкомпонентная композиция

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190111

Patent event code: PA01051R01D

Comment text: International Patent Application

AMND Amendment
PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200401

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210728

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20220222

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210728

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20220222

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20211028

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20200401

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20190130

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20220328

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20220224

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20220222

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20211028

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20200401

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20190130

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220509

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220509

End annual number: 3

Start annual number: 1

PG1601 Publication of registration